With the aim of protecting more and more Greek patients, a new product in Cardiovascular Medicine is launched. KERENDIA is now available for patients with CKD & Type 2 Diabetes. Welcome to Bayer Hellas internal Kerendia launch event, focusing on educating & preparing the Sales Team for a successful product promotion in the Greek market. In this event, you familiarized yourselves with the promotional materials & the role plays. This is the first POAP related to a pharmaceutical product. If you received this POAP, you are a True Pioneer in the Web3 space. Bayer is proudly promoting innovative practices. https://www.bayer.com/en/poap-tc

Konrad is a Software Engineer, leads the Automation an Architecture team and is working on the digital transformation.

Part of the Clinical Trial Technology and strategy group. Bringing new technology and services to our organisation

Heading a team responsible for clinical operations systems.

Head of Disease Biology IT, supporting scientists in Pharma research with IT applications and platforms to manage, mine and leverage their data and come up or validate new therapeutic hypothesis.

I am Julia, part of DS&AI - DSG.

I studied piano performance and toxicology, and am now Master Data Manager at Bayer Pharma in the R&D Master Data Management team of Data Science & AI. I am passionate about team collaboration and rowing. Currently, I'm co-leading the IDMP Ontology, an international cross-industry project with 12 pharma companies for the unique identification of medicinal products to ensure patient safety. Talk to me about common standards and high quality data for better ML and AI outcomes, our next collaboration project, and/or our next jam session at the Bayer Berlin campus.

After nearly 10 years of working experience within the field of Eventmanagment in the upscale gastronomy I've joined the Bayer Pharma Family in 2018. For the last 5 years, I first worked as an administrative assistant in the TA Thrombosis team in Clinical Development and later I've supported various projects as a member of the SPO Project Management Team.

This is the first F2F meeting in the DS & AI group and I am happy to participate as member of the DS3 sub team.

Joined Bayer in 2019 and supporting various functions of R&D. Recently moved to DA&AI group.